Assessing the effect of vitamin B1 and vitamin C on treatment of sever sepsis
Phase 3
Recruiting
- Conditions
- sepsis.Other sepsis
- Registration Number
- IRCT20210518051339N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 86
Inclusion Criteria
presence of sever sepsis based on the diagnosis of expert doctor of infectious diseases
the age up of 18
the patient or his accompany can give Informed consent
Exclusion Criteria
allergic reaction to vitamin B1 and vitamin C
patients can exit from study with their tendency
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measure of mortality. Timepoint: 4 days after beginning of consumption of B1 and C vitamines. Method of measurement: report of doctor.
- Secondary Outcome Measures
Name Time Method Recovery. Timepoint: 4 days after consumption of B1 and C vitamines. Method of measurement: report of doctor.;Duration of hospitalization. Timepoint: 4 days after consumption of B1 and C vitamines. Method of measurement: report of doctor.